Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP844880.RANbaOmGpf2XNHm_cZkh31GNpzzl-PT_O4HCvJPXAlK_E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP844880.RANbaOmGpf2XNHm_cZkh31GNpzzl-PT_O4HCvJPXAlK_E130_assertion type Assertion NP844880.RANbaOmGpf2XNHm_cZkh31GNpzzl-PT_O4HCvJPXAlK_E130_head.
- NP844880.RANbaOmGpf2XNHm_cZkh31GNpzzl-PT_O4HCvJPXAlK_E130_assertion description "[Oncogenic events in cancer cells (e.g., expression of mutant K- ras, EGFR, PTEN or p53) lead to an increase in TF levels and activity, and thereby promote tumor aggressiveness, angiogenesis, and hypercoagulability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844880.RANbaOmGpf2XNHm_cZkh31GNpzzl-PT_O4HCvJPXAlK_E130_provenance.
- NP844880.RANbaOmGpf2XNHm_cZkh31GNpzzl-PT_O4HCvJPXAlK_E130_assertion evidence source_evidence_literature NP844880.RANbaOmGpf2XNHm_cZkh31GNpzzl-PT_O4HCvJPXAlK_E130_provenance.
- NP844880.RANbaOmGpf2XNHm_cZkh31GNpzzl-PT_O4HCvJPXAlK_E130_assertion SIO_000772 16479463 NP844880.RANbaOmGpf2XNHm_cZkh31GNpzzl-PT_O4HCvJPXAlK_E130_provenance.
- NP844880.RANbaOmGpf2XNHm_cZkh31GNpzzl-PT_O4HCvJPXAlK_E130_assertion wasDerivedFrom befree-20140225 NP844880.RANbaOmGpf2XNHm_cZkh31GNpzzl-PT_O4HCvJPXAlK_E130_provenance.
- NP844880.RANbaOmGpf2XNHm_cZkh31GNpzzl-PT_O4HCvJPXAlK_E130_assertion wasGeneratedBy ECO_0000203 NP844880.RANbaOmGpf2XNHm_cZkh31GNpzzl-PT_O4HCvJPXAlK_E130_provenance.